Alkaline 0 8 0 8 B-clinical_variable
phosphatase 9 20 9 20 I-clinical_variable
must 21 25 21 25 O
be 26 28 26 28 O
≤4X 29 32 29 32 O
the 33 36 33 36 I-upper_bound
institutional 37 50 37 50 I-upper_bound
upper 51 56 51 56 I-upper_bound
limit 57 62 57 62 I-upper_bound
of 63 65 63 65 I-upper_bound
normal 66 72 66 72 I-upper_bound
( 73 74 73 74 I-upper_bound
ULN 74 77 74 77 I-upper_bound
) 77 78 77 78 I-upper_bound

All 0 3 79 82 O
patients 4 12 83 91 O
must 13 17 92 96 O
be 18 20 97 99 O
consented 21 30 100 109 O
prior 31 36 110 115 O
to 37 39 116 118 O
chemotherapy 40 52 119 131 B-treatment

Appropriate 0 11 132 143 O
studies 12 19 144 151 O
will 20 24 152 156 O
be 25 27 157 159 O
undertaken 28 38 160 170 O
in 39 41 171 173 O
patients 42 50 174 182 O
receiving 51 60 183 192 O
HAART 61 66 193 198 B-treatment
therapy 67 74 199 206 I-treatment
, 74 75 206 207 O
when 76 80 208 212 O
indicated 81 90 213 222 O

Because 0 7 223 230 O
no 8 10 231 233 O
dosing 11 17 234 240 O
or 18 20 241 243 O
toxicity 21 29 244 252 O
data 30 34 253 257 O
are 35 38 258 261 O
currently 39 48 262 271 O
available 49 58 272 281 O
on 59 61 282 284 O
the 62 65 285 288 O
use 66 69 289 292 O
of 70 72 293 295 O
oxaliplatin 73 84 296 307 B-treatment
in 85 87 308 310 O
patients 88 96 311 319 O
< 97 98 320 321 O
18 98 100 321 323 B-upper_bound
years 101 106 324 329 I-upper_bound
of 107 109 330 332 O
age 110 113 333 336 B-age

ECOG 0 4 337 341 B-clinical_variable
0 5 6 342 343 B-lower_bound
- 6 7 343 344 O
2 7 8 344 345 B-upper_bound

Gastrointestinal 0 16 346 362 B-chronic_disease
ailments 17 25 363 371 I-chronic_disease
that 26 30 372 376 O
may 31 34 377 380 O
alter 35 40 381 386 O
the 41 44 387 390 O
absorption 45 55 391 401 O
of 56 58 402 404 O
oral 59 63 405 409 O
medications 64 75 410 421 O
( 76 77 422 423 O
i.e. 77 81 423 427 O
bowel 82 87 428 433 B-chronic_disease
obstruction 88 99 434 445 I-chronic_disease
, 99 100 445 446 O
short 101 106 447 452 B-chronic_disease
- 106 107 452 453 I-chronic_disease
gut 107 110 453 456 I-chronic_disease
syndrome 111 119 457 465 I-chronic_disease
) 119 120 465 466 O

Intraperitoneal 0 15 467 482 O
ports 16 21 483 488 O
may 22 25 489 492 O
be 26 28 493 495 O
placed 29 35 496 502 O
during 36 42 503 509 O
or 43 45 510 512 O
at 46 48 513 515 O
any 49 52 516 519 O
time 53 57 520 524 O
separate 58 66 525 533 O
from 67 71 534 538 O
surgical 72 80 539 547 B-treatment
debulking 81 90 548 557 I-treatment

Non 0 3 558 561 B-pregnancy
- 3 4 561 562 I-pregnancy
pregnant 4 12 562 570 I-pregnancy
status 13 19 571 577 O
will 20 24 578 582 O
be 25 27 583 585 O
determined 28 38 586 596 O
in 39 41 597 599 O
all 42 45 600 603 O
women 46 51 604 609 B-gender
of 52 54 610 612 O
childbearing 55 67 613 625 O
potential 68 77 626 635 O

Patients 0 8 636 644 O
must 9 13 645 649 O
be 14 16 650 652 O
≥18 17 20 653 656 O
years 21 26 657 662 I-lower_bound
of 27 29 663 665 O
age 30 33 666 669 B-age

Patients 0 8 670 678 O
must 9 13 679 683 O
have 14 18 684 688 O
a 19 20 689 690 O
histologically 21 35 691 705 O
documented 36 46 706 716 O
peritoneal 47 57 717 727 B-cancer
carcinomatosis 58 72 728 742 I-cancer
from 73 77 743 747 O
either 78 84 748 754 O
colorectal 85 95 755 765 B-cancer
or 96 98 766 768 O
appendiceal 99 110 769 780 B-cancer
adenocarcinoma 111 125 781 795 I-cancer

Patients 0 8 796 804 O
must 9 13 805 809 O
have 14 18 810 814 O
adequate 19 27 815 823 O
renal 28 33 824 829 O
function 34 42 830 838 O
prior 43 48 839 844 O
to 49 51 845 847 O
chemotherapy 52 64 848 860 B-treatment
defined 65 72 861 868 O
as 73 75 869 871 O
serum 76 81 872 877 B-clinical_variable
creatinine 82 92 878 888 I-clinical_variable
≤ 93 94 889 890 O
2.0 95 98 891 894 O
mg 99 101 895 897 O
/ 101 102 897 898 O
dl 102 104 898 900 O
or 105 107 901 903 O
creatinine 108 118 904 914 B-clinical_variable
clearance 119 128 915 924 I-clinical_variable
≥60 129 132 925 928 O
ml.min/1.73 133 144 929 940 I-lower_bound
m² 145 147 941 943 I-lower_bound
for 148 151 944 947 O
patients 152 160 948 956 O
with 161 165 957 961 O
creatinine 166 176 962 972 O
levels 177 183 973 979 O
above 184 189 980 985 O
2.0 190 193 986 989 O
mg 194 196 990 992 O
/ 196 197 992 993 O
dl 197 199 993 995 O

Patients 0 8 996 1004 O
must 9 13 1005 1009 O
have 14 18 1010 1014 O
recovered 19 28 1015 1024 O
from 29 33 1025 1029 O
uncontrolled 34 46 1030 1042 B-chronic_disease
intercurrent 47 59 1043 1055 I-chronic_disease
illness 60 67 1056 1063 I-chronic_disease
including 68 77 1064 1073 O
, 77 78 1073 1074 O
but 79 82 1075 1078 O
not 83 86 1079 1082 O
limited 87 94 1083 1090 O
to 95 97 1091 1093 O
, 97 98 1093 1094 O
ongoing 99 106 1095 1102 O
or 107 109 1103 1105 O
active 110 116 1106 1112 B-chronic_disease
infection 117 126 1113 1122 I-chronic_disease
, 126 127 1122 1123 O
symptomatic 128 139 1124 1135 O
congestive 140 150 1136 1146 B-chronic_disease
heart 151 156 1147 1152 I-chronic_disease
failure 157 164 1153 1160 I-chronic_disease
, 164 165 1160 1161 O
unstable 166 174 1162 1170 B-chronic_disease
angina 175 181 1171 1177 I-chronic_disease
pectoris 182 190 1178 1186 I-chronic_disease
, 190 191 1186 1187 O
or 192 194 1188 1190 O
cardiac 195 202 1191 1198 B-chronic_disease
arrhythmias 203 214 1199 1210 I-chronic_disease

Patients 0 8 1211 1219 O
must 9 13 1220 1224 O
have 14 18 1225 1229 O
undergone 19 28 1230 1239 O
debulking 29 38 1240 1249 B-treatment
surgery 39 46 1250 1257 I-treatment
with 47 51 1258 1262 O
peritonectomy 52 65 1263 1276 B-treatment
and 66 69 1277 1280 O
have 70 74 1281 1285 O
been 75 79 1286 1290 O
allowed 80 87 1291 1298 O
at 88 90 1299 1301 O
least 91 96 1302 1307 O
4 97 98 1308 1309 B-lower_bound
weeks 99 104 1310 1315 I-lower_bound
to 105 107 1316 1318 O
recover 108 115 1319 1326 O
prior 116 121 1327 1332 O
to 122 124 1333 1335 O
receiving 125 134 1336 1345 O
chemotherapy 135 147 1346 1358 B-treatment

Patients 0 8 1359 1367 O
receiving 9 18 1368 1377 O
antiretroviral 19 33 1378 1392 B-treatment
therapy 34 41 1393 1400 I-treatment
Highly 42 48 1401 1407 B-treatment
Active 49 55 1408 1414 I-treatment
Anti 56 60 1415 1419 I-treatment
Retroviral 61 71 1420 1430 I-treatment
Treatment 72 81 1431 1440 I-treatment
( 82 83 1441 1442 I-treatment
HAART 83 88 1442 1447 I-treatment
) 88 89 1447 1448 I-treatment
for 90 93 1449 1452 O
HIV 94 97 1453 1456 B-chronic_disease
infection 98 107 1457 1466 O
are 108 111 1467 1470 O
excluded 112 120 1471 1479 O
from 121 125 1480 1484 O
the 126 129 1485 1488 O
study 130 135 1489 1494 O
because 136 143 1495 1502 O
of 144 146 1503 1505 O
possible 147 155 1506 1514 O
pharmacokinetic 156 171 1515 1530 O
interactions 172 184 1531 1543 O

Patients 0 8 1544 1552 O
with 9 13 1553 1557 O
Grade 14 19 1558 1563 B-lower_bound
2 20 21 1564 1565 I-lower_bound
or 22 24 1566 1568 O
higher 25 31 1569 1575 O
peripheral 32 42 1576 1586 B-clinical_variable
neuropathy 43 53 1587 1597 I-clinical_variable

Pregnant 0 8 1598 1606 B-pregnancy

Prior 0 5 1607 1612 O
history 6 13 1613 1620 O
of 14 16 1621 1623 O
hypersensitivity 17 33 1624 1640 O
reactions 34 43 1641 1650 O
to 44 46 1651 1653 O
oxaliplatin 47 58 1654 1665 B-allergy_name
, 58 59 1665 1666 O
bevacizumab 60 71 1667 1678 B-allergy_name
, 71 72 1678 1679 O
5 73 74 1680 1681 B-allergy_name
- 74 75 1681 1682 I-allergy_name
FU 75 77 1682 1684 I-allergy_name
or 78 80 1685 1687 O
capecitabine 81 93 1688 1700 B-allergy_name

Provided 0 8 1701 1709 O
the 9 12 1710 1713 O
patient 13 20 1714 1721 O
has 21 24 1722 1725 O
been 25 29 1726 1730 O
allowed 30 37 1731 1738 O
at 38 40 1739 1741 O
least 41 46 1742 1747 O
4 47 48 1748 1749 B-lower_bound
weeks 49 54 1750 1755 I-lower_bound
to 55 57 1756 1758 O
recover 58 65 1759 1766 O
from 66 70 1767 1771 O
surgical 71 79 1772 1780 B-treatment
debulking 80 89 1781 1790 I-treatment
, 89 90 1790 1791 O
no 91 93 1792 1794 O
additional 94 104 1795 1805 O
recovery 105 113 1806 1814 O
time 114 118 1815 1819 O
is 119 121 1820 1822 O
required 122 130 1823 1831 O
for 131 134 1832 1835 O
port 135 139 1836 1840 O
placement 140 149 1841 1850 O

The 0 3 1851 1854 O
patient 4 11 1855 1862 O
should 12 18 1863 1869 O
not 19 22 1870 1873 O
have 23 27 1874 1878 O
any 28 31 1879 1882 O
serious 32 39 1883 1890 O
medical 40 47 1891 1898 O
of 48 50 1899 1901 O
psychiatric 51 62 1902 1913 B-chronic_disease
illness 63 70 1914 1921 I-chronic_disease
that 71 75 1922 1926 O
would 76 81 1927 1932 O
prevent 82 89 1933 1940 O
either 90 96 1941 1947 O
the 97 100 1948 1951 O
giving 101 107 1952 1958 O
of 108 110 1959 1961 O
informed 111 119 1962 1970 O
consent 120 127 1971 1978 O
or 128 130 1979 1981 O
the 131 134 1982 1985 O
receipt 135 142 1986 1993 O
of 143 145 1994 1996 O
treatment 146 155 1997 2006 O

Total 0 5 2007 2012 B-clinical_variable
bilirubin 6 15 2013 2022 I-clinical_variable
must 16 20 2023 2027 O
be 21 23 2028 2030 O
< 24 25 2031 2032 O
2X 25 27 2032 2034 B-upper_bound
the 28 31 2035 2038 I-upper_bound
institutional 32 45 2039 2052 I-upper_bound
upper 46 51 2053 2058 I-upper_bound
limit 52 57 2059 2064 I-upper_bound
of 58 60 2065 2067 I-upper_bound
normal 61 67 2068 2074 I-upper_bound
( 68 69 2075 2076 I-upper_bound
ULN 69 72 2076 2079 I-upper_bound
) 72 73 2079 2080 I-upper_bound

Transaminases 0 13 2081 2094 B-clinical_variable
( 14 15 2095 2096 O
SGOT 15 19 2096 2100 B-clinical_variable
and/or 20 26 2101 2107 O
SGPT 27 31 2108 2112 B-clinical_variable
) 31 32 2112 2113 O
must 33 37 2114 2118 O
be 38 40 2119 2121 O
≤3X 41 44 2122 2125 O
the 45 48 2126 2129 I-upper_bound
institutional 49 62 2130 2143 I-upper_bound
upper 63 68 2144 2149 I-upper_bound
limit 69 74 2150 2155 I-upper_bound
of 75 77 2156 2158 I-upper_bound
normal 78 84 2159 2165 I-upper_bound
( 85 86 2166 2167 I-upper_bound
ULN 86 89 2167 2170 I-upper_bound
) 89 90 2170 2171 I-upper_bound

absolute 0 8 2172 2180 B-clinical_variable
neutrophil 9 19 2181 2191 I-clinical_variable
count 20 25 2192 2197 I-clinical_variable
≥1,500 26 32 2198 2204 O
/ 32 33 2204 2205 I-lower_bound
mm³ 33 36 2205 2208 I-lower_bound

all 0 3 2209 2212 O
sexually 4 12 2213 2221 O
active 13 19 2222 2228 O
patients 20 28 2229 2237 O
, 28 29 2237 2238 O
the 30 33 2239 2242 O
use 34 37 2243 2246 B-contraception_consent
of 38 40 2247 2249 I-contraception_consent
adequate 41 49 2250 2258 I-contraception_consent
contraception 50 63 2259 2272 I-contraception_consent
( 64 65 2273 2274 O
hormonal 65 73 2274 2282 B-contraception_consent
or 74 76 2283 2285 O
barrier 77 84 2286 2293 B-contraception_consent
method 85 91 2294 2300 I-contraception_consent
of 92 94 2301 2303 I-contraception_consent
birth 95 100 2304 2309 I-contraception_consent
control 101 108 2310 2317 I-contraception_consent
) 108 109 2317 2318 O
will 110 114 2319 2323 O
be 115 117 2324 2326 O
required 118 126 2327 2335 O
during 127 133 2336 2342 O
therapy 134 141 2343 2350 B-treatment
, 141 142 2350 2351 O
prior 143 148 2352 2357 O
to 149 151 2358 2360 O
study 152 157 2361 2366 O
entry 158 163 2367 2372 O
, 163 164 2372 2373 O
and 165 168 2374 2377 O
for 169 172 2378 2381 O
the 173 176 2382 2385 O
duration 177 185 2386 2394 O
of 186 188 2395 2397 O
study 189 194 2398 2403 O
participation 195 208 2404 2417 O

have 0 4 2418 2422 O
received 5 13 2423 2431 O
prior 14 19 2432 2437 O
chemotherapy 20 32 2438 2450 B-treatment

hemoglobin 0 10 2451 2461 B-clinical_variable
≥8 11 13 2462 2464 O
g 14 15 2465 2466 I-lower_bound
/ 15 16 2466 2467 I-lower_bound
dl 16 18 2467 2469 I-lower_bound

must 0 4 2470 2474 O
undergo 5 12 2475 2482 O
a 13 14 2483 2484 O
peritoneal 15 25 2485 2495 O
scan 26 30 2496 2500 O
documenting 31 42 2501 2512 O
at 43 45 2513 2515 O
least 46 51 2516 2521 O
one 52 55 2522 2525 O
working 56 63 2526 2533 O
intraperitoneal 64 79 2534 2549 O
port 80 84 2550 2554 O
prior 85 90 2555 2560 O
to 91 93 2561 2563 O
receiving 94 103 2564 2573 O
chemotherapy 104 116 2574 2586 B-treatment

platelet 0 8 2587 2595 B-clinical_variable
count 9 14 2596 2601 I-clinical_variable
≥100,000 15 23 2602 2610 O
/ 23 24 2610 2611 I-lower_bound
mm³ 24 27 2611 2614 I-lower_bound

